Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Switzerland
/
Pharmaceuticals & Biotech
Create a narrative
Roche Holding Community
SWX:ROG Community
2
Narratives
written by author
0
Comments
on narratives written by author
182
Fair Values set
on narratives written by author
Create a narrative
Roche Holding
Popular
Undervalued
Overvalued
Community Investing Ideas
Roche Holding
BA
bazza
Community Contributor
Roche Holding will see a 4.2576% revenue growth shaking the market
Valuation ### **Analyse der Roche Jahreszahlen 2024: Wachstum setzt sich fort, Herausforderungen bleiben_20250130 #### Zusammenfassung der Ergebnisse Roche hat für das Jahr 2024 ein solides Wachstum von 7 % auf 60,5 Mrd. CHF erzielt, was die Erwartungen leicht übertroffen hat.
View narrative
CHF 302.06
FV
19.3% undervalued
intrinsic discount
5.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
2 months ago
author updated this narrative
Roche Holding
AN
AnalystConsensusTarget
Consensus Narrative from 20 Analysts
Advancing 7 New Therapies And Poseida Acquisition Will Expand Presence In Oncology By 2025
Key Takeaways Successful Pharma pipeline and innovative diagnostics launches are anticipated to drive long-term revenue growth and operating profit. Investments in strategic R&D and acquisition capabilities aim to enhance core profit and sustain competitive position in medicine development.
View narrative
CHF 315.38
FV
22.7% undervalued
intrinsic discount
3.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
122
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
ROG
ROG
Roche Holding
Your Fair Value
CHF
Current Price
CHF 243.80
1.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
75b
2015
2018
2021
2024
2025
2027
2030
Revenue CHF 75.4b
Earnings CHF 10.0b
Advanced
Set Fair Value